Aikaterini Apostolopoulou

Dr. Aikaterini Apostolopoulou

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2020 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
ATAntigoni Tranidou
Antigoni Tranidou
Themistoklis DagklisThemistoklis Dagklis
Themistoklis Dagklis
Ioannis TsakiridisIoannis Tsakiridis
Ioannis Tsakiridis
ASA. Siargkas
A. Siargkas
AAAikaterini Apostolopoulou
Aikaterini Apostolopoulou
MCMichael Chourdakis
Michael Chourdakis

27 January 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
AAAikaterini Apostolopoulou
Aikaterini Apostolopoulou
ATAntigoni Tranidou
Antigoni Tranidou
Ioannis TsakiridisIoannis Tsakiridis
Ioannis Tsakiridis
EMEmmanuella Magriplis
Emmanuella Magriplis
Themistoklis DagklisThemistoklis Dagklis
Themistoklis Dagklis
MCMichael Chourdakis
Michael Chourdakis
The early life theory states that the first 1000 days of a person’s life are highly influential, as lasting health impacts can be attained during this period

7 February 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
ATAntigoni Tranidou
Antigoni Tranidou
Themistoklis DagklisThemistoklis Dagklis
Themistoklis Dagklis
EMEmmanuella Magriplis
Emmanuella Magriplis
AAAikaterini Apostolopoulou
Aikaterini Apostolopoulou
Ioannis TsakiridisIoannis Tsakiridis
Ioannis Tsakiridis
MCMichael Chourdakis
Michael Chourdakis
Gestational Diabetes Mellitus (GDM) is a growing epidemic affecting pregnant women and their offspring. This study aimed to identify the relationship between adherence to a Mediterranean diet (MD) before conception and the risk of GDM in a contemporary Greek pregnant cohort. A prospective cohort of pregnant women was recruited at the routine first trimester visit. Nutritional intake was evaluated using a population specific validated food frequency questionnaire (FFQ). Pre-pregnancy adherence to MD was derived using two different scoring systems, the Mediterranean diet index score (MDS), and a modified version. Adjusted odds ratios (aOR) were computed using multiple logistic regression models for each score derived. Of 743 participating women, 112 (15.1%) developed GDM. The MDS index showed that scoring 5–9 points (high adherence) was associated with a lower GDM incidence (aOR: 0.57 95% CI (0.32, 0.90), p = 0.02), while the modified MDS index showed no significant association for any level of adherence. Pre-pregnancy consumption of “meat and derivatives” and “fatty meat and processed meat” was associated with a higher risk of GDM, with both scoring systems (p = 0.008, p = 0.004, respectively). A higher adherence to a MD pre-pregnancy, especially with less meat consumption, may have a protective effect on the occurrence of GDM.

29 December 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
ATAntigoni Tranidou
Antigoni Tranidou
Ioannis TsakiridisIoannis Tsakiridis
Ioannis Tsakiridis
AAAikaterini Apostolopoulou
Aikaterini Apostolopoulou
TXTheodoros Xenidis
Theodoros Xenidis
NPNikolaos Pazaras
Nikolaos Pazaras
Themistoklis DagklisThemistoklis Dagklis
Themistoklis Dagklis
Gestational diabetes mellitus (GDM) is a significant health concern with adverse outcomes for both pregnant women and their offspring. Recognizing the need for early intervention, this study aimed to develop an early prediction model for GDM risk assessment during the first trimester. Utilizing a prospective cohort of 4917 pregnant women from the Third Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Greece, the study sought to combine maternal characteristics, obstetric and medical history, and early pregnancy-specific biomarker concentrations into a predictive tool. The primary objective was to create a series of predictive models that could accurately identify women at high risk for developing GDM, thereby facilitating early and targeted interventions. To this end, maternal age, body mass index (BMI), obstetric and medical history, and biomarker concentrations were analyzed and incorporated into five distinct prediction models. The study’s findings revealed that the models varied in effectiveness, with the most comprehensive model combining maternal characteristics, obstetric and medical history, and biomarkers showing the highest potential for early GDM prediction. The current research provides a foundation for future studies to refine and expand upon the predictive models, aiming for even earlier and more accurate detection methods.

Verified
Journal Article
Open access
PDF file
DGDionysios Gazis
Dionysios Gazis
ATAntigoni Tranidou
Antigoni Tranidou
ASAntonios Siargkas
Antonios Siargkas
AAAikaterini Apostolopoulou
Aikaterini Apostolopoulou
GKGeorgia Koutsouki
Georgia Koutsouki
Themistoklis DagklisThemistoklis Dagklis
Themistoklis Dagklis
Background/Objectives: As the incidence of diabetes mellitus (DM) is increasing rapidly worldwide, it is anticipated that an increasing number of women will enter pregnancy with pregestational diabetes mellitus (PGDM) in the future. Compelling evidence suggests that hyperglycemia in pregnancy is related to multiple adverse perinatal outcomes. This systematic review and meta-analysis aims to assess and quantify the association of PGDM with a range of adverse perinatal outcomes, providing a comprehensive understanding of its impact on pregnancy. Methods: The data sources of this systematic review and meta-analysis were Medline/PubMed, Scopus and Cochrane Library (January 1999 to August 2023), complemented by hand-searching for additional references. Observational studies reporting perinatal outcomes of pregnancies with PGDM diagnosed before pregnancy versus control pregnancies were eligible for inclusion. A systematic review and meta-analysis were conducted as per the PRISMA guidelines. Pooled estimate odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to determine the risk of adverse pregnancy outcomes between PGDM and control pregnancies. Results: The systematic search of the literature yielded 81 observational studies meeting inclusion criteria and in total, 137,237,640 pregnancies were included in the analysis. A total of 19 adverse perinatal outcomes were assessed, revealing a significant association with PGDM. In pregnancies with PGDM there was an increased risk of adverse perinatal outcomes, including gestational hypertension (OR 3.16, 95% CI 2.65–3.77), preeclampsia (OR 4.46, 95% CI 3.94–5.05), preterm delivery (OR 3.46, 95% CI 3.06–3.91), cesarean delivery (OR 3.12, 95% CI 2.81–3.47), induction of labor (OR 2.92, 95% CI 2.35–3.63), macrosomia (OR 2.23, 95% CI 1.76–2.83), LGA neonates (OR 3.95, 95% CI 3.47–4.49), low 5-min Apgar score (OR 2.49, 95% CI 2.07–2.99), shoulder dystocia (OR 3.05, 95% CI 2.07–4.50), birth trauma (OR 1.40, 95% CI 1.22–1.62), polyhydramnios (OR 5.06, 95% CI 4.33–5.91), oligohydramnios (OR 1.61, 95% CI 1.19–2.17), neonatal hyperbilirubinemia (OR 3.45, 95% CI 2.51–4.74), neonatal hypoglycemia (OR 19.19, 95% CI 2.78–132.61), neonatal intensive care unit (NICU) admission (OR 4.54, 95% CI 3.87–5.34), congenital malformations (OR 2.44, 95% CI 1.96–3.04), stillbirth (OR 2.87, 95% CI 2.27–3.63) and perinatal mortality (OR 2.94, 95% CI 2.18–3.98). Subgroup analyses indicated a higher risk of neonatal hypoglycemia, stillbirth and perinatal mortality in T1DM pregnancies compared with T2DM pregnancies. Conclusions: This study provides a robust synthesis of evidence underlying the strong association between PGDM and several adverse perinatal outcomes. Early detection, optimal glycemic control during the periconceptional and pregnancy periods, and proper antenatal care are critical to mitigate these risks.

14 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
INIoannis Nedos
Ioannis Nedos
SZSofia-Chrysovalantou Zagalioti
Sofia-Chrysovalantou Zagalioti
CKChristos Kofos
Christos Kofos
TKTheoni Katsikidou
Theoni Katsikidou
DVDimitra Vellidou
Dimitra Vellidou
BFBarbara Fyntanidou
Barbara Fyntanidou
Background: Large language models (LLMs) are increasingly proposed as clinical decision support tools. However, their reliability in the emergency department (ED) triage remains insufficiently validated. This study aimed to evaluate the performance and limitations of multiple LLMs in triage using a large retrospective dataset. Methods: We conducted a retrospective analysis of 39,375 anonymized patient cases from the ED of AHEPA University General Hospital, Thessaloniki, Greece (June 2024–July 2025), extracted from the hospital’s electronic medical record system. All cases were triaged in real time according to the Emergency Severity Index (ESI) by 25 emergency physicians. In cases of uncertainty, a senior emergency physician was consulted. Seven LLMs (ChatGPT-5 Thinking, ChatGPT-5 Instant, Gemini 2.5, Qwen 3, Grok 4.0, Deep Seek v3.1, and Claude Sonnet 4) were evaluated against the physician-assigned ESI level (reference standard). Outcomes included triage score agreement (quadratic weighted kappa, κw), clinic referral accuracy and admission prediction. Subgroup analyses were performed by referral clinic and admission outcome. The study was conducted in accordance with TRIPOD-AI reporting guidelines. Results: Model performance varied substantially. DeepSeek and Claude Sonnet 4 achieved the highest agreement with physician-assigned ESI (κw ≈ 0.467; raw accuracy: 61.7%). In contrast, GPT-5 Instant performed poorly across all evaluation metrics (κw = 0.176; 95% CI: 0.167–0.186). Claude Sonnet 4 demonstrated the best performance in clinic referral (67.1%; κ = 0.619) and admission prediction (κw ≈ 0.46). Subgroup analyses indicated higher performance in pediatric cases and organ-specific complaints, such as ophthalmology (up to 81% accuracy). LLMs also showed tendencies toward over- or under-triage. Conclusions: Current LLMs demonstrate promising but inconsistent capability in triage. While selected models achieved moderate alignment with physician ESI decisions, none achieved strong agreement (κ > 0.80). LLMs are most suitable as supervised decision support tools, particularly in anatomically well-defined clinical scenarios, rather than as autonomous systems.